Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma

被引:8
|
作者
Politi, Anastasia [1 ]
Tsiamb, Evangelos [2 ]
Mastronikolis, Nicholas S. [3 ]
Peschos, Dimitrios [4 ]
Asproudis, Ioannis [5 ]
Kyrodimos, Efthymios [6 ]
Armata, Ilianna E. [7 ]
Chrysovergis, Aristeidis [6 ]
Asimakopoulos, Asimakis [8 ]
Papanikolaou, Vasileios S. [6 ]
Batistatou, Anna [9 ]
Ragos, Vasileios [10 ]
机构
[1] Univ Ioannina, Med Sch, Dept Oncol, Ioannina, Greece
[2] 401 GAH, Dept IHC & Mol Biol, Athens, Greece
[3] Univ Patras, Med Sch, ENT Dept, Patras, Greece
[4] Univ Ioannina, Med Sch, Dept Physiol, Ioannina, Greece
[5] Univ Ioannina, Med Sch, Dept Ophthalmol, Ioannina, Greece
[6] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, IST ENT Dept, Athens, Greece
[7] Cambridge Univ Hosp, Med Sch, Cambridge, England
[8] Luxembourg Hosp Ctr, ENT Dept, Luxembourg, Luxembourg
[9] Univ Ioannina, Med Sch, Dept Pathol, Ioannina, Greece
[10] Univ Ioannina, Med Sch, Dept Maxillofacial, Ioannina, Greece
来源
IN VIVO | 2019年 / 33卷 / 03期
关键词
Carcinoma; larynx; EGFR; ALK; GROWTH-FACTOR RECEPTOR; CANCER; ALK; NECK; HEAD; MET; SURVIVAL; GENE;
D O I
10.21873/invivo.11544
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Epidermal growth factor receptor (EGFR) acts as an oncogene in malignancies. Our aim was to examine the role of combined EGFR/ anaplastic lymphoma kinase (ALK) expression as molecular markers in laryngeal squamous cell carcinoma (LSCC) patients. Materials and Methods: Fifty (n=50) tissue sections derived from twenty-five (n=25) primary LSCCs were analyzed by immunohistochemistry (IHC). Results: EGFR overexpression was observed in 17/25 (68%) cases. Concerning ALK, 23/25 (92%) demonstrated low expression. EGFR expression was associated with grade (p=0.049), whereas ALK expression was correlated with stage (p=0.048). ALK overexpression was detected at advanced-stage EGFR-positive cases. A biphasic EGFR protein expression pattern was observed in five (n=5) LSCC cases, whereas ALK expression was stable in all cases. Conclusion: EGFR overexpression is frequently observed in LSCC combined with low ALK expression. LSCC patients with EGFR/ALK protein overexpression should be eligible for targeted therapeutic strategies.
引用
收藏
页码:815 / 819
页数:5
相关论文
共 50 条
  • [1] Prognostic relevance of EGFR expression in laryngeal squamous cell carcinoma (LSCC)
    Besma, L.
    Mhiri, M.
    El Hadj, O. El Amine
    Gargouri, F.
    Kammoun, C.
    Bouziani, A.
    Msakni, I.
    VIRCHOWS ARCHIV, 2017, 471 : S152 - S153
  • [2] Gene expression analysis of laryngeal squamous cell carcinoma
    Placa, Jessica Rodrigues
    de Barros e Lima Bueno, Rafaela
    Pinheiro, Daniel Guariz
    Panepucci, Rodrigo Alexandre
    de Araujo, Luiza Ferreira
    Martins Mamede, Rui Celso
    Alves Figueiredo, David Livingstone
    Silva, Wilson Araujo, Jr.
    GENOMICS DATA, 2015, 5 : 9 - 12
  • [3] Comprehensive Analysis of HPV Expression in Laryngeal Squamous Cell Carcinoma
    Gheit, Tarik
    Abedi-Ardekani, Behnoush
    Carreira, Christine
    Missad, Carlos G.
    Tommasino, Massimo
    Torrente, Mariela C.
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (04) : 642 - 646
  • [4] Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma
    Mirko Kontić
    Jovica Milovanović
    Zaviša Čolović
    Nikola Kolja Poljak
    Željko Šundov
    Ante Sučić
    Valdi Pešutić-Pisac
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 401 - 405
  • [5] Association between EGFR expression and clinical outcome of laryngeal HPV squamous cell carcinoma
    Kontic, Mirko
    Colovic, Zavisa
    Paladin, Ivan
    Gabelica, Mirko
    Baric, Ana
    Pesutic-Pisac, Valdi
    ACTA OTO-LARYNGOLOGICA, 2019, 139 (10) : 913 - 917
  • [6] Epidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinoma
    Kontic, Mirko
    Milovanovic, Jovica
    Colovic, Zavisa
    Poljak, Nikola Kolja
    Sundov, Zeljko
    Sucic, Ante
    Pesutic-Pisac, Valdi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (02) : 401 - 405
  • [7] EGFR amplification and mutations landscape in laryngeal squamous cell carcinoma
    Kyrodimos, Efthymios
    Chrysovergis, Aristeidis
    Tsiambas, Evangelos
    Papanikolaou, Vasileios S.
    JOURNAL OF BUON, 2019, 24 (05): : 2205 - 2206
  • [8] Combined modality treatment of laryngeal squamous cell carcinoma
    Devlin, John G.
    Langer, Corey J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) : 331 - 350
  • [9] Protein expression analysis for predicting recurrent laryngeal squamous cell carcinoma
    Thanasan, Siwaporn
    Ruangritchankul, Komkrit
    Kitkumthorn, Nakarin
    Keelawat, Somboon
    Mahattanasakul, Patnarin
    BIOMEDICAL REPORTS, 2024, 20 (01)
  • [10] 218 Cases of EGFR/ALK Gene Status Analysis in Chinese Lung Squamous Cell Carcinoma
    Xu, C.
    Wang, W.
    Zhuang, W.
    Song, Z.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2248 - S2248